muito interessante

2586

᭿

Tratado de Clínica Médica

CAPÍTULO 224

1. BAEKER, A. F.; BARDANA, E. J. Bronchiectasis: update of an orphan disease.
Am. Rev. Dis., v. 137, p. 969-978, 1998.
2. NICOTRA, M. B. Bronchiectasis. Semin. Respir. Infect., v. 9, p. 31-40, 1994.
3. SWARTZ, M. N. Bronchiectasis. In: FISHMAN, A. P. Pulmonary Disease and
Disorders. New York: McGraw-Hill, 1998. p. 1553-1581.
4. GOMES, M.; HONDA, A.; BARBOSA, A. G.; FERRAZZI, M. A. T. Bronquiectasias: correlação entre exacerbação e sazonalidade. J. Pneumol., v. 28, supl. 2, p.
S112, 2002.
5. WILSON, C. B.; JONES, P. W.; O’LEAREY, C. J.; HANSELL, D. M.; COLE, P.
J.; WILSON, R. Effect of sputum bacteriology on the quality of life of patients with bronchiectasis. Eur. Respir. J., v. 10, p. 1754-1760, 1997.
6. NICOTRA, M. B.; RIVERA, A. M.; DALE, R. S.; CARTER, R. Clinical, pathophysiologic and microbiologic characterization of bronchiectasis in an aging cohort. Chest, v. 108, p. 955-9561, 1995.
7. LIN, H. C.; CHENG, H. F.; WANG, C. H.; LIU, C. Y.; YU, C. T.; KUO, H. P.
Inhaled Gentamicin Reduces Airway Neutrophil Activity and Mucus Secretion in
Bronchiectasis. Am. J. Respir. Crit. Care Med., v. 155, p. 2024-2029, 1999.
8. ILOWITE, J. S.; NIEDERMAN, M. S.; FEIN, A. M. Delivery of topical antibiotics: pharmacokinetics and clinical problems. Semin. Respir. Infect., v. 6, p. 158-167,
1991.
9. BARKER, A. F.; COUCH, L.; FIEL, S. B.; GOTFRIED, M. H.; ILOWITE, J.;
MEYER, K. C. et al. Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis. Am. J. Respir. Crit. Care Med., v. 162, p.
481-485, 2000.
10. KOLBE, J.; WELLS, A.; RAM, F. S. F. Inhaled steroids for bronchiectasis (Cochrane
Review). In: The Cochrane Library. Oxford: Update Software, 2002. issue 4.
11. LASSERSON, T.; HOLT, K.; GREENSTONE, M. Oral steroids for bronchiectasis
(stable and acute exacerbations) (Cochrane Review). In: The Cochrane Library.
Oxford: Update Software, 2002. issue 4.
12.